167 related articles for article (PubMed ID: 29788903)
1. Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials.
Peura DA; Le Moigne A; Wassel H; Pollack C
BMC Gastroenterol; 2018 May; 18(1):69. PubMed ID: 29788903
[TBL] [Abstract][Full Text] [Related]
2. A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.
Peura D; Le Moigne A; Pollack C; Nagy P; Lind T
Postgrad Med; 2016 Aug; 128(6):577-83. PubMed ID: 27331882
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 2-Week Data from Two Randomized, Controlled Trials Conducted in Subjects with Frequent Heartburn Treated with Esomeprazole 20 mg.
Katz PO; Le Moigne A; Pollack C
Clin Ther; 2017 May; 39(5):960-970. PubMed ID: 28431766
[TBL] [Abstract][Full Text] [Related]
4. Esomeprazole treatment of frequent heartburn: two randomized, double-blind, placebo-controlled trials.
Peura DA; Traxler B; Kocun C; Lind T
Postgrad Med; 2014 Jul; 126(4):33-41. PubMed ID: 25141241
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.
Johnson DA; Le Moigne A; Li J; Pollack C; Nagy P
Clin Drug Investig; 2016 Jul; 36(7):531-8. PubMed ID: 27074935
[TBL] [Abstract][Full Text] [Related]
6. Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment.
Miner PB; Johnson DA; Katz PO; Li J; Gatoulis SC; Pollack C
Adv Ther; 2018 Nov; 35(11):2024-2040. PubMed ID: 30255418
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the symptom response to esomeprazole 20 mg over days 1-4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials.
Peura D; Le Moigne A; Wassel H; Pollack C
BMJ Open Gastroenterol; 2019; 6(1):e000278. PubMed ID: 31297231
[TBL] [Abstract][Full Text] [Related]
8. Rapid resolution of sleep disturbances related to frequent reflux: effect of esomeprazole 20 mg in two randomized, double-blind, controlled trials.
Johnson DA; Le Moigne A; Hugo V; Nagy P
Curr Med Res Opin; 2015 Feb; 31(2):243-50. PubMed ID: 25478944
[TBL] [Abstract][Full Text] [Related]
9. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors.
Boardman HF; Heeley G
Int J Clin Pharm; 2015 Oct; 37(5):709-16. PubMed ID: 26100836
[TBL] [Abstract][Full Text] [Related]
10. Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.
Fass R; Sontag SJ; Traxler B; Sostek M
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):50-6. PubMed ID: 16431305
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis--results from the EXPO study.
Labenz J; Armstrong D; Zetterstrand S; Eklund S; Leodolter A
Aliment Pharmacol Ther; 2009 May; 29(9):959-66. PubMed ID: 19222417
[TBL] [Abstract][Full Text] [Related]
12. The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease.
Jha LK; Maradey-Romero C; Gadam R; Hershcovici T; Fass OZ; Quan SF; Guillen J; Fass R
Neurogastroenterol Motil; 2015 Feb; 27(2):237-45. PubMed ID: 25484104
[TBL] [Abstract][Full Text] [Related]
13. Obesity does not affect treatment outcomes with proton pump inhibitors.
Sharma P; Vakil N; Monyak JT; Silberg DG
J Clin Gastroenterol; 2013 Sep; 47(8):672-7. PubMed ID: 23442835
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.
Xue Y; Qin X; Zhou L; Lin S; Wang L; Hu H; Xia J
Clin Drug Investig; 2016 Dec; 36(12):985-992. PubMed ID: 27605258
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial: A double-blind, proof-of-concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro-esophageal reflux disease and partial response to a healing dose of a proton-pump inhibitor.
Tack J; Vladimirov B; Horny I; Chong CF; Eisner J; Czerniak R; Takanami Y
Neurogastroenterol Motil; 2023 Jan; 35(1):e14468. PubMed ID: 36178335
[TBL] [Abstract][Full Text] [Related]
16. Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn.
Johnsson F; Hatlebakk JG; Klintenberg AC; Román J
Scand J Gastroenterol; 2003 Apr; 38(4):347-53. PubMed ID: 12739705
[TBL] [Abstract][Full Text] [Related]
17. Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies.
Kushner PR; Snoddy AM; Gilderman L; Peura DA
Postgrad Med; 2009 Jul; 121(4):67-75. PubMed ID: 19641272
[TBL] [Abstract][Full Text] [Related]
18. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
[TBL] [Abstract][Full Text] [Related]
19. Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis.
Katz PO; Castell DO; Levine D
Aliment Pharmacol Ther; 2003 Nov; 18(9):875-82. PubMed ID: 14616151
[TBL] [Abstract][Full Text] [Related]
20. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Gut; 2014 May; 63(5):720-6. PubMed ID: 23831734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]